Related by context. Frequent words. (Click for all words.) 69 Pivotal Phase III 69 active comparator 69 peg IFN 68 Phase Ib clinical 68 nab paclitaxel 67 sustained virologic response 67 phase IIa 67 placebo controlled clinical 67 Phase 2b study 67 Phase 2a trial 67 Pivotal Phase 67 TELCYTA 67 mycophenolate mofetil 67 plus prednisone 67 mg kg dose 66 events SAEs 66 double blinded placebo 66 metastatic hormone refractory 66 relapsed refractory multiple myeloma 66 plus dexamethasone 66 diabetic neuropathic pain 66 peginterferon alfa 2b 66 tolvaptan 66 pertuzumab 66 Amrubicin 66 peginterferon 65 adecatumumab 65 mcg kg 65 virologic failure 65 Phase IIa trial 65 PRECiSE 65 plus ribavirin 65 placebo controlled studies 65 tocilizumab 65 phase IIb 65 peginterferon alfa 2a 65 HCV genotype 1 65 valopicitabine 65 placebo controlled trials 65 irbesartan 64 mg QD 64 administered subcutaneously 64 PROMACTA 64 plus methotrexate 64 eltrombopag 64 pegylated interferon 64 elagolix 64 dose cohorts 64 sunitinib 64 Multicenter 64 LY# [003] 64 SCH # 64 mg BID 64 Phase 2a clinical 64 HER2 positive metastatic breast 64 multicenter randomized 64 CR# vcMMAE 63 SABCS 63 Fludara 63 multicenter clinical 63 dacarbazine 63 patients evaluable 63 nilotinib 63 gout flares 63 FOLFIRI 63 pharmacodynamic effects 63 dose regimens 63 metastatic renal cell carcinoma 63 entecavir 63 achieved statistical significance 63 nitazoxanide 63 randomized Phase III 63 Pivotal Trial 63 ADXS# 63 BAY #-# 63 Phase III Clinical Trial 63 TORISEL 63 Torisel 63 interferon alfa 63 adefovir 63 Phase 1b clinical 63 dasatinib 63 vicriviroc 63 ocrelizumab 63 blinded placebo controlled 63 glatiramer acetate 62 romiplostim 62 axitinib 62 bosentan 62 alvimopan 62 Telcyta 62 Navelbine 62 ZD# [001] 62 mcg dose 62 phase 2a 62 6R BH4 62 evaluable 62 FOLFOX 62 valacyclovir 62 enalapril 62 Taxotere ®